Clinical trial Recruiting at 1 site Interventional Ages 18 to 56 Women only

EUmetriosis: new insights into how endometriosis develops

Official title: EUmetriosis: Insights Into the Pathogenesis of Endometriosis

Run by Université Catholique de Louvain · NCT07000786 · Data updated 2026-11-12

This study will see if epigenetic changes in menstrual blood and plasma can be used to find a non-invasive test for women with endometriosis.

Quick facts

Study typeInterventional
Ages18 Years to 56 Years
SexWomen only
Enrollment60 (estimated)
SponsorUniversité Catholique de Louvain
Academic / other
Locations1 site (Brussels)
StatusRecruiting
StartedMay 12, 2025
Main results expectedDecember 31, 2029
Study endsDecember 31, 2029
Registry record updatedJune 3, 2025
Trial IDNCT07000786 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are premenopausal women in a spontaneous (non-hormonally treated) menstrual cycle, either healthy or with endometriosis confirmed by ultrasound, MRI, or laparoscopy.

Probably not a fit

Women who are pregnant, currently using hormonal treatments, or who are HIV- or hepatitis-positive will not qualify and thus will not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study collects menstrual effluent (via menstrual cup or endometrial biopsy) and blood samples from premenopausal women in natural menstrual cycles, including those with a confirmed diagnosis of endometriosis and healthy controls. Researchers will analyze epigenetic marks in menstrual and plasma samples to look for patterns that distinguish women with endometriosis from those without. Participants must not have used hormonal treatments in the prior three months and are excluded if pregnant or HIV/hepatitis positive. The goal is to identify candidate non-invasive biomarkers that could reduce reliance on invasive diagnostic procedures.

Why it matters

Potential benefit: If successful, this could lead to a non-invasive menstrual or blood test that helps diagnose endometriosis earlier and reduce the need for surgery.

How similar studies have gone: Previous research has found epigenetic differences in endometrial tissue and some blood-based signals, but robust, clinically validated non-invasive biomarkers for endometriosis have not yet been established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Premenopausal
* In spontaneous menstrual cycle (no hormonal treatments for the last 3 months)
* Healthy or with a clear diagnosis of endometriosis via ultrasound, MRI or laparoscopy

Exclusion Criteria:

* HIV or Hepatitis positive
* Pregnancy

Where it's running

  • Cliniques universitaires Saint-Luc
    Brussels, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.